National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

testolactone
A progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Fludestrin
Therapeutic Testolactone
US brand name:Teslac
Abbreviation:TL
Code name:SQ-9538
Chemical structure names:
  • 1,2,3,4,4a,4b,7,9,10,10a-Decahydro-2-hydroxy-2,4b-dimethyl-7-oxo-1-phenanthrenepropionic Acid Delta-Lactone
  • 13-Hydroxy-3-0x0-13,17-secoandrosta-1,4-dien-17-oic Acid Delta-Lactone
  • 17Alpha-oxo-D-homo-1,4-androstadiene-3,17-dione
  • 1-Dehydrotestololactone
  • Delta-1-Testololactone
  • D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione



Previous:terephthalamidine, teroxirone, Teslac, TESPA, Testoderm
Next:Testolin, testosterone gel, Testostroval, Testostroval-PA, Testro AQ

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov